UPDATE: Biogen's (BIIB) Conference Cancellation Said Due to Scheduling Conflict
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
(Updated - August 11, 2016 1:51 PM EDT)
Biogen (NASDAQ: BIIB) canceled an appearance at a Citi conference due to a scheduling conflict, according to market chatter. CNBC later confirmed the rumor.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB), Forward Pharma (FWP) Enter Settlement and License Agreement; Biogen to Pay $1.25B, Royalties
- Biogen's (BIIB) IP Settlement Removes Significant Overhang - Baird
- Netflix, Inc. (NFLX) volatility elevated, shares near record high into Q4